About us
Introduction
Quality forum
Medicines UK structure
Medicines UK executive team
Our members
Associate members
Disclosure
Our core focus
Patients
Quality
Value
Sustainability
Partnership
Key issues
Introduction
Generic Pricing
Benefits to the NHS
Current supply issues
Patient access
Patient information
Freedom in market pricing
Getting to market
Sustainability
MHRA performance
Better Patent Regulation
Biosimilars
Falsified Medicines Directive
Industry-NHS guidance
About generics
Introduction
Industry overview
The generics industry
Studies on the generic medicines market in the UK
Generics FAQs
News
Current news
Information
Join us
Introduction
Associate Membership
Associate Members
Contact us
About us
Introduction
Quality forum
Medicines UK structure
Medicines UK executive team
Our members
Associate members
Disclosure
Our core focus
Patients
Quality
Value
Sustainability
Partnership
Key issues
Introduction
Generic Pricing
Benefits to the NHS
Current supply issues
Patient access
Patient information
Freedom in market pricing
Getting to market
Sustainability
MHRA performance
Better Patent Regulation
Biosimilars
Falsified Medicines Directive
Industry-NHS guidance
About generics
Introduction
Industry overview
The generics industry
Studies on the generic medicines market in the UK
Generics FAQs
News
Current news
Information
Join us
Introduction
Associate Membership
Associate Members
Contact us
Biosimilars
Current news
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2015
08.12.2015
Medicines UK coordinates patient safety update with MHRA
15.10.2015
Regulatory efficiency report 2015
28.09.2015
Secondary medical use patents
24.09.2015
What is biosimilar medicine?
03.09.2015
Medicines UK welcomes positive appraisal for biosimilar infliximab
04.08.2015
Medicines UK welcomes NICE biosimilar resource on Inflixmab
15.06.2015
FMD to feature as part of next Medicines UK/MHRA Quality Forum
25.02.2015
Infliximab launch is milestone in development of UK biosimilars industry
16.02.2015
New Thinking Required To Sustain Future Market Shifts
30.01.2015
Medicines UK Response to Branded Medicines Consultation
16.01.2015
Medicines UK and MHRA Come Together for Quality Forum
Highlights
25.06.2020
Life Sciences Recovery Roadmap
16.06.2020
Reaction to dexamethasone treatment for Covid-19 patients
02.04.2020
Statement of intent for UK life sciences
25.03.2020
COVID-19 Medicines UK update
20.03.2020
Key worker welcome
18.03.2020
Covid-19 statement
04.03.2020
Response to today's CMA fines on anti-competitive agreements
06.02.2020
Reaction to the Government's document on the UK's approach to trade deals with non-EU nations